A global correction
First, please read the Disclaimer.
Strong red candles across major market indices warn of a global correction.
Breach of 3650 on the S&P 500 would warn of a test of the strong band of support between 3250 and 3400. Bearish divergence on Twiggs Money Flow continues to warn of long-term selling pressure.
The European Stoxx 600 threatens a similar secondary correction with a test of support at 375.
The Footsie is testing support between 6300 and 6500, while Money Flow reversal below zero warns of strong selling pressure. Breach of 6300 is likely and would indicate a strong correction, with primary support at 5500.
The reaction on China's Shanghai Composite is of similar weight to the S&P and STOXX. Breach of medium-term support at 3400 would warn of a test of primary support at 3200.
The reaction on Japan's Nikkei 225 appears secondary and likely to test the rising trendline at 26000.
The Seoul Composite is similar, with a rising trendline at 2700.
Selling on India's Nifty 50 is heavier, flagged by a sharp fall in Money Flow over the past three weeks. Support at the rising trendline is unlikely to hold -- which would mean a test of support at 12500.
Conclusion
The correction across global stock markets appears secondary at this stage and likely to test medium-term support levels. Selling is heaviest on the FTSE 100 and India's Nifty 50. These are the canary in the coal mine and should be monitored for unusual activity. Further falls on strong volume would indicate that sellers are overwhelming support.
Quote for the Week
As an American I heartily welcome the return of normal-stupid politics, when everybody lies, does a pretty bad job, & MSM [mainstream media] obscures, but nobody's worried if POTUS owes the Kremlin a billion large, and he's not gonna try to get VPOTUS lynched by his superfans in fur Viking attire.
~ John Schindler, former NSA Analyst
Updates for Market Analysis Subscribers
Please take advantage of our $1 special offer for the first month. Cancel at any time.
Disclaimer
Colin Twiggs is director of The Patient Investor Pty Ltd, an Authorised Representative (no. 1256439) of MoneySherpa Pty Limited which holds Australian Financial Services Licence No. 451289.
Everything contained in this web site, related newsletters, training videos and training courses (collectively referred to as the "Material") has been written for the purpose of teaching analysis, trading and investment techniques. The Material neither purports to be, nor is it intended to be, advice to trade or to invest in any financial instrument, or class of financial instruments, or to use any particular methods of trading or investing.
Advice in the Material is provided for the general information of readers and viewers (collectively referred to as "Readers") and does not have regard to any particular person's investment objectives, financial situation or needs. Accordingly, no Reader should act on the basis of any information in the Material without properly considering its applicability to their financial circumstances. If not properly qualified to do this for themselves, Readers should seek professional advice.
Investing and trading involves risk of loss. Past results are not necessarily indicative of future results.
The decision to invest or trade is for the Reader alone. We expressly disclaim all and any liability to any person, with respect of anything, and of the consequences of anything, done or omitted to be done by any such person in reliance upon the whole or any part of the Material.
Please read the Financial Services Guide.